Ascentage Pharma Group International (AAPG) Receivables (2023 - 2025)
Historic Receivables for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $10.8 million.
- Ascentage Pharma Group International's Receivables changed N/A to $10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year change of. This contributed to the annual value of $12.4 million for FY2024, which is 4241.31% down from last year.
- Ascentage Pharma Group International's Receivables amounted to $10.8 million in Q2 2025.
- In the past 5 years, Ascentage Pharma Group International's Receivables registered a high of $21.2 million during Q4 2023, and its lowest value of $10.8 million during Q2 2025.
- For the 3-year period, Ascentage Pharma Group International's Receivables averaged around $14.8 million, with its median value being $12.4 million (2024).
- Examining YoY changes over the last 5 years, Ascentage Pharma Group International's Receivables showed a top increase of 4132.89% in 2024 and a maximum decrease of 4132.89% in 2024.
- Over the past 3 years, Ascentage Pharma Group International's Receivables (Quarter) stood at $21.2 million in 2023, then tumbled by 41.33% to $12.4 million in 2024, then dropped by 12.84% to $10.8 million in 2025.
- Its last three reported values are $10.8 million in Q2 2025, $12.4 million for Q4 2024, and $21.2 million during Q4 2023.